Product Recalls in Louisiana

Product recalls affecting Louisiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Louisiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,678 recalls have been distributed to Louisiana in the last 12 months.

51,202 total recalls
2,678 in last 12 months

Showing 84618480 of 13,548 recalls

DrugDecember 28, 2016· Dr. Reddy's Laboratories, Inc.

Recalled Item: Flucanozole Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to Failed...

The Issue: Failed Dissolution Specifications; 18 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 28, 2016· Dr. Reddy's Laboratories, Inc.

Recalled Item: Flucanozole Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to Failed...

The Issue: Failed Dissolution Specifications; 18 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 28, 2016· Dr. Reddy's Laboratories, Inc.

Recalled Item: Flucanozole Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to Failed...

The Issue: Failed Dissolution Specifications; 18 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 28, 2016· L. Perrigo Company

Recalled Item: Clindamycin Phosphate and Benzoyl Peroxide Gel Recalled by L. Perrigo...

The Issue: Microbial Contamination of Non-Sterile Product; small number of tubes may...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 28, 2016· Dr. Reddy's Laboratories, Inc.

Recalled Item: Flucanozole Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to Failed...

The Issue: Failed Dissolution Specifications; 18 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 27, 2016· The Harvard Drug Group

Recalled Item: Aripiprazole Tablets Recalled by The Harvard Drug Group Due to Superpotent...

The Issue: Superpotent Drug; out of specification results for assay (manufacturer)

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 22, 2016· Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals

Recalled Item: TEMAZEPAM CAPSULES USP Recalled by Vintage Pharmaceuticals LLC, DBA...

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 22, 2016· Aurobindo Pharma USA Inc

Recalled Item: Venlafaxine Hydrochloride extended release capsules Recalled by Aurobindo...

The Issue: Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 22, 2016· Roxane Laboratories, Inc.

Recalled Item: Furosemide Tablets USP Recalled by Roxane Laboratories, Inc. Due to Failed...

The Issue: Failed Tablet/Capsule Specifications: An unusually thick tablet was reported...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: buPROPion Hydrochloride Extended-release Tablets Recalled by Sun...

The Issue: Failed Dissolution Specifications; 18 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 20, 2016· Accord Healthcare, Inc.

Recalled Item: Lisinopril tablets Recalled by Accord Healthcare, Inc. Due to Failed...

The Issue: Failed tablet/capsule specification: missing break line on the 5mg tablet.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2016· Mylan LLC.

Recalled Item: Temozolomide Capsules Recalled by Mylan LLC. Due to Failed Tablet/Capsule...

The Issue: Failed Tablet/Capsule Specifications: customer complaints of broken or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2016· Mylan LLC.

Recalled Item: Temozolomide Capsules Recalled by Mylan LLC. Due to Failed Tablet/Capsule...

The Issue: Failed Tablet/Capsule Specifications: customer complaints of broken or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2016· Sun Pharmaceutical Industries, Inc.

Recalled Item: buPROPion Hydrochloride Extended-release Tablets Recalled by Sun...

The Issue: Failed Dissolution Specifications; 18 month stability time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 20, 2016· Mylan LLC.

Recalled Item: Temozolomide Capsules Recalled by Mylan LLC. Due to Failed Tablet/Capsule...

The Issue: Failed Tablet/Capsule Specifications: customer complaints of broken or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2016· Mylan LLC.

Recalled Item: Temozolomide Capsules Recalled by Mylan LLC. Due to Failed Tablet/Capsule...

The Issue: Failed Tablet/Capsule Specifications: customer complaints of broken or...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 19, 2016· Apotex Inc.

Recalled Item: Aripiprazole Tablets Recalled by Apotex Inc. Due to Superpotent Drug:...

The Issue: Superpotent Drug: Product may not meet specifications throughout shelf life.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2016· Aurobindo Pharma USA Inc

Recalled Item: Pantoprazole Sodium for Injection Recalled by Aurobindo Pharma USA Inc Due...

The Issue: Discoloration: Some vials were found to contain powder with a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugDecember 16, 2016· Fresenius Kabi USA, LLC

Recalled Item: MIDAZOLAM INJECTION Recalled by Fresenius Kabi USA, LLC Due to Failed...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 14, 2016· Roxane Laboratories, Inc.

Recalled Item: Azelastine Hydrochloride Nasal Solution (Nasal Spray) Recalled by Roxane...

The Issue: Defective Delivery System: out of specification result for droplet size...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund